market-access scaling-innovation-across-hospitals-and-nations 
pharmaphorum
OCTOBER 2, 2020
The five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical trials in the UK by offering new ways to conduct late-phase, large-scale research projects. How they can serve as a test bed for pharmaceutical innovation.
pharmaphorum
NOVEMBER 10, 2021
That’s according to a newly published report from the US National Academies of Sciences, Engineering, and Medicine, which calls for a One Health approach that recognises the scale of the challenge, and the interconnectivity of its potential solutions. Growing threat of AMR. And it costs $4.6
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
OCTOBER 2, 2020
The five new NHS Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical trials in the UK by offering new ways to conduct late-phase, large-scale research projects. How they can serve as a test bed for pharmaceutical innovation. How the centres will provide quicker and easier clinical studies.
pharmaphorum
JANUARY 5, 2021
These are the crisis of healthcare system capacity and non COVID-19 patient backlog, and the economic crisis, still largely to come in impact, which will constrain healthcare spend, both public and private, across countries and have knock-on impacts for medicines spend. Yet these things have happened. Healthcare systems reconfigure.
pharmaphorum
DECEMBER 10, 2020
A new network of patient recruitment centres is set to shape the future of commercial clinical trials in the UK by offering new approaches to conduct late-phase, large-scale research projects. They have also been designed to improve the speed and consistency through which commercial research is delivered in the NHS. Yan Yiannakou.
pharmaphorum
JULY 9, 2021
Ampersand Health has been working in the space since 2015 and has seen it evolve from a niche approach with limited acceptance to widespread acceptance and deployment across disease areas in a matter of years. There’s an enormous market for similar approaches in other disease areas. “In
ISPE
SEPTEMBER 11, 2023
Cauchon, PhD 1 September 2023 The biopharmaceutical industry must develop and implement innovative ways of working to be effective and efficient in the current healthcare ecosystem, in which high-quality medicines, adaptability, and assurance of supply are of critical importance.
Expert insights. Personalized for you.
92 
Let's personalize your content